Active Ingredient(S)
Guaifenesin 600 mg (for 600mg)
Guaifenesin 1200 mg (for 1200 mg)
The following Structured Product Label (SPL) was submitted to the FDA by Dr. Reddy's Laboratories Inc. for the product Guaifenesin 1200 Mg (NDC 43598-108). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, use(s), warnings, do not use, ask a doctor before use if, stop use and ask doctor if, if pregnancy/breastfeeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 600 mg (for 600mg)
Guaifenesin 1200 mg (for 1200 mg)
Expectorant
Applicable warning(s) in 201.66(c)(5)(i) and (ii)
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
cough accompanied by too much phlegm (mucus)
ask a health professional before use.
In case of overdose, get medical help or contact aPoison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, ferric oxide red, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A
call 1-888-375-3784 Weekdays (9am - 8pm EST)
You may also report side effects to this phone number.
Guaifenesin Extended-Release Tablets 600 mg Carton Label
Guaifenesin Extended-Release Tablets 1200 mg Carton Label
* Please review the disclaimer below.